Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2013
10/23/2013CN102755559B Traditional Chinese medicine composition for treating non-gonococcal urethritis
10/23/2013CN102719329B Liquid perfumed soap
10/23/2013CN102643346B Antibiotic containing antibody simulant and pharmacy application for same
10/23/2013CN102641394B Traditional Chinese medicine composite for treating allergic rhinitis
10/23/2013CN102626515B Process for activating Haemophilus influenzae type b (Hib) polysaccharide conjugate vaccine
10/23/2013CN102526467B Chinese medicinal composition for treating pulmonary fungal infection and preparation method thereof
10/23/2013CN102512536B Compound propolis composition for treating haemophilus parasuis and preparation method for same
10/23/2013CN102512377B Tasteless quick-releasing berberine hydrochloride pellet
10/23/2013CN102430114B Compound propolis composition for treating porcine parvovirus disease and preparation method thereof
10/23/2013CN102406718B Normal-temperature preparation method of ultramicro Bailong powde
10/23/2013CN102397408B Compound antiviral oral liquid for poultry and preparation method thereof
10/23/2013CN102370638B Application of 3,3'-diindolylmethane and 3,3'-diindolylmethane derivatives in preparation of drugs for treating liver diseases
10/23/2013CN102357153B Traditional Chinese medicine for treating herpes zoster
10/23/2013CN102249982B Pleuromutilin compound, and medical composition, preparation method and application thereof
10/23/2013CN102233132B Application of VEGF acceptor fusion proteins in preparation of drugs for inhibiting growth of ocular surface neovascularization
10/23/2013CN102140430B Mouse-typhus salmonella gene-deletion mutant strain without containing resistance marks, vaccine and application thereof
10/23/2013CN102068473B Medicinal composition, preparation method, preparation and application thereof
10/23/2013CN101896197B Polysaccharide immunogens from clostridium difficile
10/23/2013CN101856347B Extract of leontopodic acid plant and application of active ingredients thereof in treating hepatitis
10/23/2013CN101663312B Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
10/22/2013US8563562 Compounds having antiviral properties
10/22/2013US8563506 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
10/22/2013US8563503 Antibiotic, its nucleotide sequence, methods of construction and uses thereof
10/22/2013US8563236 Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
10/22/2013US8563007 Immunogenic compositions for the prevention and treatment of meningococcal disease
10/22/2013US8563006 Immunogenic compositions for the prevention and treatment of meningococcal disease
10/22/2013US8562994 Human-murine chimeric antibodies against respiratory syncytial virus
10/22/2013US8562952 Methods for manipulating satiety
10/22/2013CA2607572C Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use
10/22/2013CA2473526C Polyalkylene polymer compounds and uses thereof
10/22/2013CA2457488C Antimicrobial agent
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/22/2013CA2359926C Antagonists of hmg1 for treating inflammatory conditions
10/17/2013WO2013155375A1 Enhanced anti-influenza agents conjugated with anti-inflammatory activity
10/17/2013WO2013154793A1 F2 derivatives as antibacterial agents
10/17/2013WO2013154016A1 Ophthalmic composition
10/17/2013WO2013153821A1 Pdk4 inhibitor and use thereof
10/17/2013WO2013153800A1 Method for producing lymphocyte cell group consisting mainly of memory t cells
10/17/2013WO2013153535A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS
10/17/2013WO2013153532A1 Phthalocyanine compounds useful as reca inhibitors and methods of using same
10/17/2013WO2013153394A1 Quinolonones with antibacterial properties
10/17/2013WO2013153372A1 Bacterial vaccine
10/17/2013WO2013153358A1 Probiotic bacteria
10/17/2013WO2013153162A1 Polymorph of rilpivirine hydrochloride
10/17/2013WO2013153111A1 Pharmaceutical composition containing an unsaturated fatty acid enriched with oxygen and an organic solvent
10/17/2013WO2013153055A1 Process for the preparation of a viral protease inhibitor in amorphous form
10/17/2013WO2013152848A1 Glycomimetics as pseudomonas aeruginosa lectin inhibitors
10/17/2013WO2013152838A1 Preparation for topical application to mucosa containing polyhexanide as active ingredient
10/17/2013WO2013152717A1 Fused pyrimidine compound, and preparation method, intermediate, composition， and uses thereof
10/17/2013WO2013152688A1 Separation and purification method for dalfopristin and intermediate thereof
10/17/2013WO2013152392A1 Viral polymerase inhibitors
10/17/2013WO2013152391A1 Viral polymerase inhibitors
10/17/2013WO2013124874A3 Glucose derivatives bound to arsenic for use in the treatment of tumour
10/17/2013WO2013104995A3 Compositions and methods for treating viral infections
10/17/2013WO2013081571A3 Isolated lyssavirus nucleic acid and protein sequences
10/17/2013WO2013042093A8 The use of the antibiotic bacitracin in the hydrolytic degradation of rna
10/17/2013WO2012096994A3 Antibodies directed against influenza
10/17/2013US20130276158 Methods and compositions for rna interference
10/17/2013US20130274309 Compositions and methods for non-parenteral delivery of oligonucleotides
10/17/2013US20130273042 Treatment of multiple sclerosis
10/17/2013US20130273009 Methods to mobilize progenitor/stem cells
10/17/2013US20130272997 Synthetic mechanical hemostatic composition, method of making and use thereof
10/17/2013US20130272964 Molecules with extended half-lives, compositions and uses thereof
10/17/2013DE102010004360A1 Emulsion for treating fungal infections prepared by removing a portion of coffee bean using a coffee spoon, and adding a liquid, water, milk, and whipped cream
10/16/2013EP2650361A1 Galectin 9-secreting cell, production method for same, and application for same
10/16/2013EP2650292A1 Thiazolamine derivative and use thereof as anti-picornaviral infection medicament
10/16/2013EP2650291A1 Crystalline Antifungal Compounds
10/16/2013EP2650289A1 Glycomimetics as pseudomonas Aeruginosa lectin inhibitors
10/16/2013EP2650285A1 Fungicide
10/16/2013EP2650284A1 Heterocyclic derivatives as metabotropic glutamate receptor modulators
10/16/2013EP2650015A2 Compositions and methods of use of ORF 554 from beta hemolytic Streptococcal strains
10/16/2013EP2650014A2 Compositions and methods of use of ORF1358 from beta-hemolytic streptococcal strains
10/16/2013EP2650008A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases
10/16/2013EP2650007A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases
10/16/2013EP2649999A1 Use of quinazoline compound in preparation of anti-flavivirus drug
10/16/2013EP2649099A2 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
10/16/2013EP2649085A1 Glycomimetic compounds as anti-infectious against pathogens lectins
10/16/2013EP2649077A1 Hiv integrase inhibitors
10/16/2013EP2649076A1 Macrocyclic inhibitors of flaviviridae viruses
10/16/2013EP2649074A1 Hiv integrase inhibitors
10/16/2013EP2649067A1 Benzofurane derivatives for the treatment of hepatitits c
10/16/2013EP2649047A1 Process for the manufacture of ajoene derivatives
10/16/2013EP2648704A1 Anti-microbial composition
10/16/2013EP2648703A1 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
10/16/2013EP2648701A1 Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
10/16/2013EP2399937A9 Anti-human alpha9 integrin antibody and use thereof
10/16/2013CN103354808A Anti-viral compounds
10/16/2013CN103352030A Vaccine comprising an attenuated pestivirus
10/16/2013CN103352029A Epidemic encephalitis B/forest encephalitis hybrid virus and application of virus
10/16/2013CN103352015A HtpsA-gene-knock-out mutant strain of Streptococcus suis serotype 2 and application thereof
10/16/2013CN103351435A Human binding molecules having killing activity against staphylococci and uses thereof
10/16/2013CN103351430A Fish nuclear factor 45 and application thereof
10/16/2013CN103351410A 1-ferrocenyl-3-[(N-(2-substituted benzimidazolyl)]-2-propylene-1-ketone and preparation method and application thereof
10/16/2013CN103351397A Gambogic acid derivative, preparation method and uses thereof
10/16/2013CN103349785A Traditional Chinese medicine volatile oil complex and preparation method thereof
10/16/2013CN103349781A Modified chimeric polypeptides with improved pharmacokinetic properties
10/16/2013CN103349780A Conjugation of streptococcal capsular saccharides
10/16/2013CN103349778A Application of CC chemotactic factor of turbot
10/16/2013CN103349763A Drug for treating acquired immune deficiency syndrome
10/16/2013CN103349755A Fenticonazole nitrate and synthesis process thereof
1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 1798